- $258.70m
- $286.66m
- $184.32m
- 94
- 41
- 18
- 49
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 45.5 | 80.1 | 130 | 158 | 184 |
Cost of Revenue | |||||
Gross Profit | 36.8 | 63.4 | 103 | 127 | 146 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 34.4 | 70 | 108 | 135 | 174 |
Operating Profit | 11.1 | 10.2 | 22.4 | 22.9 | 10.8 |
Total Net Non Operating Interest Income / Expense | |||||
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 11.9 | 10.2 | 22.3 | 22.2 | 12.6 |
Provision for Income Taxes | |||||
Net Income After Taxes | 9.49 | 9.07 | 17.1 | 17 | 9.73 |
Net Income Before Extraordinary Items | |||||
Net Income | 9.49 | 9.07 | 17.1 | 17 | 9.73 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 9.49 | 9.07 | 17.1 | 17 | 9.73 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.254 | 0.238 | 0.442 | 0.436 | 0.268 |
Special Dividends per Share |